Get introduced to the
most exciting companies in
our portfolio.

hC Bioscience

hcbioscience.com

HC Bioscience is pioneering a new category of genomic medicine through its innovative protein editing platform that utilizes engineered tRNA to correct disease-causing mutations without altering DNA or mRNA. This unique approach allows for the production of complete, functional proteins from faulty genes, positioning the company at the forefront of therapeutic development for genetically defined diseases. With a strong focus on tRNA biology, drug delivery systems, and computational analysis, HC Bioscience aims to transform patient care, particularly in conditions like hemophilia and Duchenne muscular dystrophy, by providing effective and affordable treatments.